TheEdgeResearch
Home / Stocks / CFX

Colfax Corporation (CFX)

NYSE Industrials Industrial - Machinery
$39.06 ▼ -3.77%
Market Cap
$2.12B
Sector
Industrials
Industry
Industrial - Machinery
Beta
2.12
52-Wk Range
38.88-40.67
CEO
Matthew Trerotola
Country
US
Currency
USD

Colfax Corporation operates in the Industrial - Machinery industry of the Industrials sector, headquartered in Annapolis Junction, MD, US. The stock last traded at $39.06, down 3.77% on the session, giving a market capitalisation of $2.12B. On trailing twelve-month figures it carries a trailing P/E of -2.03, a net margin of -48.0%. Its beta of 2.12 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-2.03
Price / Sales
0.92
Price / Book
1.42
EV / EBITDA
-4.61
Gross margin
61.1%
Operating margin
-46.4%
Net margin
-48.0%
Return on equity
—
Debt / equity
0.93
Current ratio
1.98
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
New York Stock Exchange
Employees
16,200
IPO date
2008-05-08
Headquarters
Annapolis Junction, MD, US
About Colfax Corporation

Colfax Corporation operates as a global, diversified technology enterprise, structured into two primary divisions: Fabrication Technology and Medical Technology. The Fabrication Technology division specializes in the formulation, development, manufacturing, and supply of consumable products and associated equipment. These are crucial for industrial applications such as cutting, joining, automated welding, and gas flow control. Its comprehensive product portfolio includes a variety of welding consumables, like electrodes, wires, and fluxes, alongside cutting consumables such as nozzles, shields, and tips. These items are distributed through independent channels and direct sales to diverse markets, including general industry, construction, infrastructure, transportation, energy, and medical and life sciences, predominantly under the ESAB brand. Conversely, the Medical Technology division is dedicated to the development, production, and distribution of advanced medical devices. These devices are utilized by a broad spectrum of healthcare practitioners, including orthopedic specialists, surgeons, physical therapists, and athletic trainers, to manage musculoskeletal conditions caused by degenerative diseases, deformities, traumatic incidents, and sports-related injuries. Its extensive product offerings encompass rigid and soft orthopedic bracing, hot and cold therapy systems, bone growth stimulators, vascular therapy solutions, therapeutic footwear, electrical stimulators for pain management, and a full range of reconstructive joint implants for areas like the hip, knee, and shoulder. Sales for this segment, primarily under the DJO brand, occur via independent distributors (such as healthcare professionals and retail pharmacies) and direct channels. Established in 1860, Colfax Corporation is headquartered in Wilmington, Delaware.

Comparable companies

Colfax Corporation is most often compared with the following Industrials names:

CIRFTAIGOGLHOLIPGTISHPWTGHTGIVRTV
More research on CFX
CFX technical analysis CFX TheEdge Score Compare against peers
Open full interactive analysis & DCF →